24 February 2023
ROLLS-ROYCE HOLDINGS PLC – 2022 Full Year Results Improved profit and cash in 2022; transformation programme underway to create a high-performing, growing and competitive…
23 February 2023
23 February 2023 07:00 GMT AstraZeneca enters license agreement with KYM Biosciences for CMG901, a Claudin-18.2 antibody drug conjugate CMG901 expands AstraZeneca’s commitment in…
ViiV Healthcare announces positive data demonstrating long-acting injectable Cabenuva (cabotegravir, rilpivirine) is as effective as daily oral Biktarvy (BIC/FTC/TAF) for the treatment of HIV-1 · 12-month findings…
BAE Systems plc Preliminary Announcement 2022 Financial highlights – Record Order intake of £37.1bn propelled Order backlog to £58.9bn. – Sales increased by 4.4%1 to £23.3bn. – Expanded…
22 February 2023
Primary Health Properties PLC Preliminary results for the year ended 31 December 2022 Record year for rental growth driving performance Primary Health Properties PLC…
Lloyds Banking Group plc 22 February 2023 CONTENTS Page Results for the full -year 1 Income statement – underlying basis and key balance sheet metrics 4…
Rio Tinto delivers underlying EBITDA of $26.3 billion and total dividends of 492 US cents per share 22 February 2023 Rio Tinto Chief Executive Jakob Stausholm said: “We are…
21 February 2023
21 February 2023 11:00 GMT Annual Financial Report AstraZeneca PLC (the Company) announced today the publication of its Annual Report and Form 20-F Information…